• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

  • in Oncology
  • — 28 Sep, 2009
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
John Burn
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
AudioMedica News
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-986"/>
John Burn

John Burn

John Burn talking at ECCO15-ESMO34 in Berlin about his international study showing that aspirin prevented the development of Hereditary Non-Polyposis Colon Cancer in people genetically at risk for the disease.



LISTEN

[audio:https://www.audiomedica.com/podcasting/otbn/090924OTBNJohnBurnPODCAST.mp3]

You may also like...

  • Peter Campbell MD PhD, head of Cancer Genetics and Genomics at the Sanger Institute in Cambridge International Research and Consensus Needed to Interpret Breast Cancer Genomics Data 27 Mar, 2015
  • PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer PSA-membrane antibody conjugate shows promise for treating metastatic castration-resistant, taxane-refractory prostate cancer 6 Feb, 2014
  • Stephen Hodi Combination immunotherapy improved overall survival in patients with metastatic melanoma 15 Sep, 2013
  • Chronic Lymphocytic Leukemia After Fludarabine Failure Chronic Lymphocytic Leukemia After Fludarabine Failure 26 Feb, 2008

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story For Early Breast Cancer, Switch to Aromatase Inhibitor after Tamoxifen Extends Survival
  • Next story Aromatase Inhibitor Better than Tamoxifen for Initial Adjuvant Therapy for HR- Positive Breast Cancer, But Compliance an Issue!
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Esophageal Cancer Prevented By Proton Pump Inhibitor…
    • Pembrolizuab Monotherapy Extended Survival in…
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths…
  • Home
  • Oncology
  • Longer Follow-up Reveals: Aspirin Prevents Cancer in Lynch Syndrome

© COPYRIGHT 2020 AUDIOMEDICA.COM.